| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9888265 | Clinica Chimica Acta | 2005 | 8 Pages |
Abstract
Xuezhikang resulted in rapid reduction of CRP within 24 h and lipid profile within 2 weeks, which may be clinically important for patients with coronary artery disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Jian-Jun Li, Sheng-Shou Hu, Chun-Hong Fang, Rui-Tai Hui, Li-Fu Miao, Yue-Jin Yang, Run-Lin Gao,